Penserra Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,490
| Closed | -$7K | – | 1405 |
|
|
2021
Q3 | $7K | Buy |
1,490
+10
| +0.7% | +$47 | ﹤0.01% | 1390 |
|
|
2021
Q2 | $9K | Buy |
1,480
+5
| +0.3% | +$30 | ﹤0.01% | 1277 |
|
|
2021
Q1 | $11K | Buy |
1,475
+415
| +39% | +$3.1K | ﹤0.01% | 1023 |
|
|
2020
Q4 | $6K | Buy |
1,060
+666
| +169% | +$3.77K | ﹤0.01% | 968 |
|
|
2020
Q3 | $2K | Buy |
+394
| New | +$2K | ﹤0.01% | 905 |
|